IDXX - Company ID 0000874716
The table below shows IDEXX LABORATORIES INC /DE's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $1.14B | $1.11B | $1.11B | $998.43M | $975.54M | $1.00B |
| Cost of revenue | $418.08M | $421.88M | $414.73M | $375.05M | $379.50M | $384.42M |
| Gross profit | $722.74M | $683.35M | $694.73M | $623.38M | $596.04M | $619.16M |
| R&D | $65.79M | $63.41M | $61.90M | $59.06M | $53.98M | $55.45M |
IDEXX LABORATORIES INC /DE reported annual revenue of $4.30B for fiscal year 2025. That is up 10.4% from $3.90B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.78B (FY 2016) to $4.30B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $119.11M | $105.94M | $98.68M | $91.56M | $91.89M | $157.24M |
| Operating income | $362.59M | $354.85M | $373.05M | $316.53M | $303.89M | $263.80M |
| Income tax | $77.00M | $70.16M | $68.36M | $67.41M | $66.07M | $55.76M |
| Net income | $278.45M | $274.61M | $293.99M | $242.68M | $232.84M | $203.30M |
| EPS (diluted) | $3.47 | $3.40 | $3.63 | $2.96 | $2.80 | $2.44 |